Literature DB >> 35347386

Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis.

Yenpo Lin1,2, Ren-Chin Wu3,4, Yen-Ling Huang1,2,3, Kueian Chen1,2,3, Shu-Chi Tseng1,2, Chin-Jung Wang3,5, Angel Chao3,5, Chyong-Huey Lai3,5, Gigin Lin6,7,8,9.   

Abstract

Uterine leiomyoma, also known as uterine fibroid, is the most common gynecological tumor, affecting almost 80% of women at some point during their lives. In the same time, other fibroid-like tumors have similar clinical presentations and about 0.5% of resected tumors of which were presumed benign fibroids in the preoperative diagnosis revealed as malignant sarcomas in the final histopathological examination. Amid the emergence of nonsurgical or minimally invasive procedures for symptomatic benign uterine fibroids, such as uterine artery embolization, high-intensity-focused ultrasound, or laparoscopic myomectomy, the preoperative diagnosis of uterine tumors through imaging becomes all the more relevant. Preoperative tissue sampling is challenging because of the variable location of the myometrial mass; thus, the preoperative evaluation of size and location is increasingly performed through magnetic resonance imaging. Features in images might also be useful for examining the full spectrum of such growths, from benign fibroids to neoplasms of uncertain behavior and malignant sarcomas. Benign fibroids include usual-type leiomyomas, myomas with degeneration, and mitotically active leiomyomas. Neoplasms of uncertain behavior include smooth muscle tumors of uncertain malignant potential, leiomyomas with bizarre nuclei, and cellular leiomyomas. Malignant sarcomas comprise leiomyosarcomas, endometrial stromal sarcomas, adenosarcomas, and carcinosarcomas. The purpose of this article is to review the spectrum of MRI findings of uterine fibroid-like tumors, from benign variants, uncertain behavior to malignant sarcomas, and update the advanced imaging modalities, including diffusion-weighted imaging, positron emission tomography/computed tomography, combining texture analysis and radiomics, to tackle this important issue.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Leiomyomas; Leiomyosarcomas; Magnetic resonance imaging; Uterine neoplasms

Mesh:

Year:  2022        PMID: 35347386     DOI: 10.1007/s00261-022-03431-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  49 in total

Review 1.  Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.

Authors:  Philip P C Ip; Ka Yu Tse; Kar Fai Tam
Journal:  Adv Anat Pathol       Date:  2010-03       Impact factor: 3.875

2.  FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.

Authors:  Malcolm G Munro; Hilary O D Critchley; Michael S Broder; Ian S Fraser
Journal:  Int J Gynaecol Obstet       Date:  2011-02-22       Impact factor: 3.561

3.  High-signal-intensity rim surrounding uterine leiomyomas on MR images: pathologic correlation.

Authors:  R L Mittl; I T Yeh; H Y Kressel
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

Review 4.  Review of Leiomyoma Variants.

Authors:  Elizabeth Kagan Arleo; Peter E Schwartz; Pei Hui; Shirley McCarthy
Journal:  AJR Am J Roentgenol       Date:  2015-10       Impact factor: 3.959

Review 5.  Epidemiology and management of uterine fibroids.

Authors:  Emma Giuliani; Sawsan As-Sanie; Erica E Marsh
Journal:  Int J Gynaecol Obstet       Date:  2020-02-17       Impact factor: 3.561

6.  Multiple plexiform tumorlets of the uterus.

Authors:  J D Seidman; R M Thomas
Journal:  Arch Pathol Lab Med       Date:  1993-12       Impact factor: 5.534

7.  Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.

Authors:  Gigin Lin; Lan-Yan Yang; Yu-Ting Huang; Koon-Kwan Ng; Shu-Hang Ng; Shir-Hwa Ueng; Angel Chao; Tzu-Chen Yen; Ting-Chang Chang; Chyong-Huey Lai
Journal:  J Magn Reson Imaging       Date:  2015-09-18       Impact factor: 4.813

Review 8.  Clinical management of uterine sarcomas.

Authors:  Frédéric Amant; An Coosemans; Maria Debiec-Rychter; Dirk Timmerman; Ignace Vergote
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

Review 9.  Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?

Authors:  Danielle DeMulder; Susan M Ascher
Journal:  AJR Am J Roentgenol       Date:  2018-10-24       Impact factor: 3.959

10.  The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.

Authors:  Ken Tamai; Takashi Koyama; Tsuneo Saga; Nobuko Morisawa; Koji Fujimoto; Yoshiki Mikami; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-10-10       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.